Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...

Discover how early functional screening at the single-cell level transforms therapeutic development of your antibodies.

The companies Biohaven, MoonLake Immunotherapeutics, and AIRNA bagged the biggest biotech funding rounds overall in April ...